VideaHealth Secures FDA Clearance for Videa Dental Assist, Now Addressing Virtually All Common Dental Disease

Company expands AI-detection capabilities with more than 30 new AI algorithms, helping tens of thousands of clinicians provide expanded patient-centric clinical care to millions of people

BOSTON--()--VideaHealth, the leading dental artificial intelligence (AI) platform, today announced the U.S. Food and Drug Administration (FDA) has issued 510(k) clearance for Videa Dental Assist, which includes more than 30 AI algorithms and expands AI detections to cover all of the most common dental diseases.

Florian Hillen, CEO of VideaHealth, said, “This is one of the largest, most impactful FDA clearances in the history of healthcare and will elevate the patient care for the tens of millions of patients who are supported per year by VideaAI. We are now the first dental AI company offering insights for virtually every disease state in dentistry as well as enabling diagnosis of pediatric conditions. It furthers VideaHealth’s mission to support thousands of dental clinicians to provide better care to millions of patients.”

The clearance applications include periapical radiolucencies, calculus, pediatric caries detection for ages three years and older as well as many other AI models that allow for subtle detections across all ages, better workflow and time-savings. Many of these detections are the first of their kind to be issued by a regulatory agency anywhere in the world, including the first pediatric radiology AI clearance in dentistry.

Dr. Tim Quirt, Senior Vice President of Clinical Operations at Heartland Dental shared, “It is exciting that VideaHealth’s scope of AI capabilities and innovations continue to expand. We are proud to partner with VideaHealth in this fast-moving field because their vision, mission and commitment to providers are unparalleled. This is another big step forward for AI to assist supported doctors and their teams in caring for their patients’ needs, and we are excited to soon offer these expanded capabilities across our supported footprint.”

Thousands of clinicians have already selected VideaAI as their dental AI tool of choice, using it daily to provide the best possible care for millions of patients. With today’s announcement, VideaHealth is now the first dental AI company to offer insights for virtually every disease state.

About VideaHealth

VideaHealth is the leading dental AI company, offering dental providers the most comprehensive suite of dental AI technology that addresses virtually every dental disease state. Practices of all sizes are using VideaHealth to drive better clinical outcomes, ranging from the nation’s largest DSO, Heartland Dental, to forward-facing independent practices.

Through a partnership with Henry Schein One, one of the country’s most respected technology companies, VideaHealth is also bringing the co-branded Dentrix Detect AI and Dentrix Ascend AI powered by VideaHealth to the tens of thousands of offices using the company’s practice management software.

Headquartered in Boston, VideaHealth is backed by leading venture capital firms Spark Capital, Zetta Venture Partners and Pillar VC. For more information, visit https://www.videa.ai

Contacts

Media
Aimee Bowen
videahealth@metiscomm.com

Contacts

Media
Aimee Bowen
videahealth@metiscomm.com